Metastatic Solid Tumors Characterized by HER2/Neu Expression
1 clinical trials · Condition
◉ Watch Metastatic Solid Tumors Characterized by HER2/Neu Expression
| Record | Firm | Date |
|---|---|---|
| Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing (NCT01730118) | National Cancer Institute (NCI) | 2013-03-04 |
Track Metastatic Solid Tumors Characterized by HER2/Neu Expression automatically
Every clearance here is in the API, with alerts when new ones post.